Search

Search Constraints

You searched for: Author/Creator Koutras, Angelos

Search Results

1. An MRI study of immune checkpoint inhibitor–induced musculoskeletal manifestations myofasciitis is the prominent imaging finding. (17th September 2019)

2. Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab. Issue 2 (12th May 2019)

3. Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy. (21st September 2018)

4. Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives. (August 2020)

5. Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients. (June 2019)

6. MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer. Issue 1 (December 2016)

7. OP0335 A PROSPECTIVE CLINICAL AND MRI STUDY OF IMMUNE CHECKPOINT INHIBITOR (ICI)-INDUCED MUSCULOSKELETAL MANIFESTATIONS MYO-FASCIITIS AND NOT SYNOVITIS IS THE PROMINENT IMAGING FINDING. (June 2019)

8. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe. Issue 1 (30th September 2017)

10. Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study. (September 2022)